Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites

Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction

(2017) Maria-Corina Serban et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Myotoxicity of statins: Mechanism of action

(2017) Patrick du Souich et al.   PHARMACOLOGY & THERAPEUTICS

GATM Polymorphism Associated with the Risk for Statin-Induced Myopathy Does Not Replicate in Case-Control Analysis of 715 Dyslipidemic Individuals

(2015) Jasmine A. Luzum et al.   Cell Metabolism

Phenotype Standardization for Statin-Induced Myotoxicity

(2014) A Alfirevic et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2

(2014) Marco Ferrari et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review

(2014) William J. Canestaro et al.   GENETICS IN MEDICINE

Increased dosage of cyclosporine induces myopathy with increased seru creatine kinase in an elderly patient on chronic statin therapy

(2014) L. Mo et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

GATM locus does not replicate in rhabdomyolysis study

(2014) James S. Floyd et al.   NATURE

International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms

(2013) K M Giacomini et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink

(2013) D F Carr et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

More Than a Billion People Taking Statins?

(2013) John P. A. Ioannidis   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education

(2013) Melissa Y. Wei et al.   Journal of Clinical Lipidology

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy

(2013) Lara M. Mangravite et al.   NATURE

The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study

(2013) Catherine E. de Keyser et al.   Pharmacogenetics and Genomics

Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients

(2013) Hon-Kit Lee et al.   PHARMACOGENOMICS

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

(2010) Michael S. Kostapanos et al.   American Journal of Cardiovascular Drugs

The genetics of statin-induced myopathy

(2009) Abhijit Ghatak et al.   ATHEROSCLEROSIS

Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins

(2009) Michael J. Knauer et al.   CIRCULATION RESEARCH

Statin induced myotoxicity: The lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro

(2008) Ine Blankenberg Skottheim et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE